Stock of the Day: Midatech Pharma PLC (Nasdaq:MTP) Up 230%

Company Profile

Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.

Profile

Sector: Health Technology

Industry: Biotechnology

Employees: 

Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes. The firm’s proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is a innovative nanosaccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is a edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale ie i. chemotherapy – improved and targeted delivery of existing chemotherapeutic agents to tumor sites, as well as ii. immunotherapy – enhanced uptake of new immuno-moieties by immune cells that can then mount an immune attack against cancer cells. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

stocktipsfortoday.com MTP 5 day chart 7/21/20

Leave a Reply

Your email address will not be published. Required fields are marked *